Target Price | JPY681.43 |
Price | JPY840.00 |
Deviation |
18.88%
register free of charge
|
Number of Estimates | 7 |
7 Analysts have issued a price target Sumitomo Dainippon Pharma 2026 .
The average Sumitomo Dainippon Pharma target price is JPY681.43.
This is
18.88%
register free of charge
JPY1,200.00
42.86%
register free of charge
JPY410.00
51.19%
register free of charge
|
|
A rating was issued by 7 analysts: 1 Analysts recommend Sumitomo Dainippon Pharma to buy, 3 to hold and 3 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Sumitomo Dainippon Pharma stock has an average upside potential 2026 of
18.88%
register free of charge
|
Mar '25 |
2026 Estimates |
|
---|---|---|
Revenue Billion JPY | 398.83 | 366.60 |
26.79% | 8.08% | |
EBITDA Margin | 13.86% | 24.32% |
130.72% | 75.49% | |
Net Margin | 5.93% | 13.18% |
105.92% | 122.42% |
7 Analysts have issued a sales forecast Sumitomo Dainippon Pharma 2026 . The average Sumitomo Dainippon Pharma sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Sumitomo Dainippon Pharma EBITDA forecast 2026. The average Sumitomo Dainippon Pharma EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Sumitomo Dainippon Pharma Analysts have issued a net profit forecast 2026. The average Sumitomo Dainippon Pharma net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Mar '25 |
2026 Estimates |
|
---|---|---|
Earnings Per Share JPY | 59.49 | 121.63 |
107.50% | 104.45% | |
P/E | 6.62 | |
EV/Sales | 1.55 |
4 Analysts have issued a Sumitomo Dainippon Pharma forecast for earnings per share. The average Sumitomo Dainippon Pharma EPS is
This results in the following potential growth metrics and future valuations:
Sumitomo Dainippon Pharma...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.